Literature DB >> 14984270

Use of glancing angle X-ray powder diffractometry to depth-profile phase transformations during dissolution of indomethacin and theophylline tablets.

Smita Debnath1, Paul Predecki, Raj Suryanarayanan.   

Abstract

PURPOSE: The purpose of this study was (i) to develop glancing angle x-ray powder diffractometry (XRD) as a method for profiling phase transformations as a function of tablet depth; and (ii) to apply this technique to (a) study indomethacin crystallization during dissolution of partially amorphous indomethacin tablets and to (b) profile anhydrate --> hydrate transformations during dissolution of theophylline tablets.
METHODS: The intrinsic dissolution rates of indomethacin and theophylline were determined after different pharmaceutical processing steps. Phase transformations during dissolution were evaluated by various techniques. Transformation in the bulk and on the tablet surface was characterized by conventional XRD and scanning electron microscopy, respectively. Glancing angle XRD enabled us to profile these transformations as a function of depth from the tablet surface.
RESULTS: Pharmaceutical processing resulted in a decrease in crystallinity of both indomethacin and theophylline. When placed in contact with the dissolution medium, while indomethacin recrystallized, theophylline anhydrate rapidly converted to theophylline monohydrate. Due to intimate contact with the dissolution medium, drug transformation occurred to a greater extent at or near the tablet surface. Glancing angle XRD enabled us to depth profile the extent of phase transformations as a function of the distance from the tablet surface. The processed sample (both indomethacin and theophylline) transformed more rapidly than did the corresponding unprocessed drug. Several challenges associated with the glancing angle technique, that is, the effects of sorbed water, phase transformations during the experimental timescale, and the influence of phase transformation on penetration depth, were addressed.
CONCLUSIONS: Increased solubility, and consequently dissolution rate, is one of the potential advantages of metastable phases. This advantage is negated if, during dissolution, the metastable to stable transformation rate >> dissolution rate. Glancing angle XRD enabled us to quantify and thereby profile phase transformations as a function of compact depth. The technique has potential utility in monitoring surface reactions, both chemical decomposition and physical transformations, in pharmaceutical systems.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14984270     DOI: 10.1023/b:pham.0000012163.89163.f8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  13 in total

Review 1.  Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes.

Authors:  K R Morris; U J Griesser; C J Eckhardt; J G Stowell
Journal:  Adv Drug Deliv Rev       Date:  2001-05-16       Impact factor: 15.470

2.  What is the true solubility advantage for amorphous pharmaceuticals?

Authors:  B C Hancock; M Parks
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

3.  Effects of sorbed water on the crystallization of indomethacin from the amorphous state.

Authors:  V Andronis; M Yoshioka; G Zografi
Journal:  J Pharm Sci       Date:  1997-03       Impact factor: 3.534

4.  A kinetic study of the crystallization process of noncrystalline indomethacin under isothermal conditions.

Authors:  M Otsuka; N Kaneniwa
Journal:  Chem Pharm Bull (Tokyo)       Date:  1988-10       Impact factor: 1.645

5.  Effect of environmental temperature on polymorphic solid-state transformation of indomethacin during grinding.

Authors:  M Otsuka; T Matsumoto; N Kaneniwa
Journal:  Chem Pharm Bull (Tokyo)       Date:  1986-04       Impact factor: 1.645

6.  Characterization of tolbutamide polymorphs (Burger's forms II and IV) and polymorphic transition behavior.

Authors:  K Kimura; F Hirayama; K Uekama
Journal:  J Pharm Sci       Date:  1999-04       Impact factor: 3.534

7.  Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate.

Authors:  A J Aguiar; J Krc; A W Kinkel; J C Samyn
Journal:  J Pharm Sci       Date:  1967-07       Impact factor: 3.534

8.  Changes in crystallinity and solubility on comminution of digoxin and observations on spironolactone and oestradiol.

Authors:  A T Florence; E G Salole
Journal:  J Pharm Pharmacol       Date:  1976-08       Impact factor: 3.765

9.  Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate.

Authors:  Y Kobayashi; S Ito; S Itai; K Yamamoto
Journal:  Int J Pharm       Date:  2000-01-05       Impact factor: 5.875

10.  Effects of dehydration temperature on water vapor adsorption and dissolution behavior of carbamazepine.

Authors:  Makoto Ono; Yuichi Tozuka; Toshio Oguchi; Shigeo Yamamura; Keiji Yamamoto
Journal:  Int J Pharm       Date:  2002-06-04       Impact factor: 5.875

View more
  5 in total

1.  Influence of processing-induced phase transformations on the dissolution of theophylline tablets.

Authors:  Smita Debnath; Raj Suryanarayanan
Journal:  AAPS PharmSciTech       Date:  2004-02-12       Impact factor: 3.246

2.  Calculation of the penetration depth of X-rays in intact pharmaceutical film-coated tablets by microdiffractometry.

Authors:  Hiroyuki Yamada; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2006-08-12       Impact factor: 4.200

3.  Investigation of solid phase composition on tablet surfaces by grazing incidence X-ray diffraction.

Authors:  Vishal Koradia; Mikko Tenho; Heidi Lopez de Diego; Michiel Ringkjøbing-Elema; Jørn Møller-Sonnergaard; Jarno Salonen; Vesa-Pekka Lehto; Jukka Rantanen
Journal:  Pharm Res       Date:  2011-07-09       Impact factor: 4.200

4.  Depth profiling of compression-induced disorders and polymorphic transition on tablet surfaces with grazing incidence X-ray diffraction.

Authors:  Mikko Koivisto; Paula Heinänen; Veli Pekka Tanninen; Vesa-Pekka Lehto
Journal:  Pharm Res       Date:  2006-02-10       Impact factor: 4.200

5.  Understanding Dissolution and Crystallization with Imaging: A Surface Point of View.

Authors:  Dunja Novakovic; Antti Isomäki; Bibi Pleunis; Sara J Fraser-Miller; Leena Peltonen; Timo Laaksonen; Clare J Strachan
Journal:  Mol Pharm       Date:  2018-10-09       Impact factor: 4.939

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.